nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—MAP2K2—islet of Langerhans—type 1 diabetes mellitus	0.00755	0.155	CbGeAlD
Trametinib—MAP2K1—cardiovascular system—type 1 diabetes mellitus	0.0062	0.127	CbGeAlD
Trametinib—MAP2K1—kidney—type 1 diabetes mellitus	0.00607	0.124	CbGeAlD
Trametinib—MAP2K2—cardiovascular system—type 1 diabetes mellitus	0.00546	0.112	CbGeAlD
Trametinib—MAP2K2—kidney—type 1 diabetes mellitus	0.00534	0.109	CbGeAlD
Trametinib—MAP2K2—pancreas—type 1 diabetes mellitus	0.00531	0.109	CbGeAlD
Trametinib—MAP2K1—lymphoid tissue—type 1 diabetes mellitus	0.00521	0.107	CbGeAlD
Trametinib—MAP2K2—lymphoid tissue—type 1 diabetes mellitus	0.00459	0.094	CbGeAlD
Trametinib—Creatinine increased—Ramipril—type 1 diabetes mellitus	0.00203	0.0485	CcSEcCtD
Trametinib—CYP2C8—kidney—type 1 diabetes mellitus	0.00185	0.0379	CbGeAlD
Trametinib—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.00176	0.0419	CcSEcCtD
Trametinib—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.00152	0.0363	CcSEcCtD
Trametinib—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.00141	0.0336	CcSEcCtD
Trametinib—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.00132	0.0314	CcSEcCtD
Trametinib—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.00128	0.0306	CcSEcCtD
Trametinib—CYP3A4—kidney—type 1 diabetes mellitus	0.00125	0.0257	CbGeAlD
Trametinib—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00119	0.0284	CcSEcCtD
Trametinib—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00116	0.0278	CcSEcCtD
Trametinib—Neutropenia—Ramipril—type 1 diabetes mellitus	0.00114	0.0271	CcSEcCtD
Trametinib—Renal failure—Ramipril—type 1 diabetes mellitus	0.00106	0.0254	CcSEcCtD
Trametinib—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00106	0.0252	CcSEcCtD
Trametinib—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00105	0.0251	CcSEcCtD
Trametinib—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00102	0.0243	CcSEcCtD
Trametinib—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.000958	0.0228	CcSEcCtD
Trametinib—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.000955	0.0228	CcSEcCtD
Trametinib—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000876	0.0209	CcSEcCtD
Trametinib—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.000868	0.0207	CcSEcCtD
Trametinib—Mental disorder—Ramipril—type 1 diabetes mellitus	0.000852	0.0203	CcSEcCtD
Trametinib—Malnutrition—Ramipril—type 1 diabetes mellitus	0.000846	0.0202	CcSEcCtD
Trametinib—Erythema—Ramipril—type 1 diabetes mellitus	0.000846	0.0202	CcSEcCtD
Trametinib—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.000829	0.0198	CcSEcCtD
Trametinib—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.000814	0.0194	CcSEcCtD
Trametinib—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000758	0.0181	CcSEcCtD
Trametinib—Cough—Ramipril—type 1 diabetes mellitus	0.000738	0.0176	CcSEcCtD
Trametinib—Myalgia—Ramipril—type 1 diabetes mellitus	0.00072	0.0172	CcSEcCtD
Trametinib—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00072	0.0172	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000716	0.0171	CcSEcCtD
Trametinib—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000705	0.0168	CcSEcCtD
Trametinib—Oedema—Ramipril—type 1 diabetes mellitus	0.000691	0.0165	CcSEcCtD
Trametinib—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000677	0.0161	CcSEcCtD
Trametinib—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000676	0.0161	CcSEcCtD
Trametinib—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000671	0.016	CcSEcCtD
Trametinib—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000668	0.0159	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.000629	0.015	CcSEcCtD
Trametinib—Insomnia—Ramipril—type 1 diabetes mellitus	0.000625	0.0149	CcSEcCtD
Trametinib—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.0006	0.0143	CcSEcCtD
Trametinib—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000596	0.0142	CcSEcCtD
Trametinib—Fatigue—Ramipril—type 1 diabetes mellitus	0.000595	0.0142	CcSEcCtD
Trametinib—Constipation—Ramipril—type 1 diabetes mellitus	0.000591	0.0141	CcSEcCtD
Trametinib—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000565	0.0135	CcSEcCtD
Trametinib—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000546	0.013	CcSEcCtD
Trametinib—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000546	0.013	CcSEcCtD
Trametinib—Asthenia—Ramipril—type 1 diabetes mellitus	0.000496	0.0118	CcSEcCtD
Trametinib—Pruritus—Ramipril—type 1 diabetes mellitus	0.000489	0.0116	CcSEcCtD
Trametinib—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000473	0.0113	CcSEcCtD
Trametinib—Dizziness—Ramipril—type 1 diabetes mellitus	0.000457	0.0109	CcSEcCtD
Trametinib—Vomiting—Ramipril—type 1 diabetes mellitus	0.000439	0.0105	CcSEcCtD
Trametinib—Rash—Ramipril—type 1 diabetes mellitus	0.000435	0.0104	CcSEcCtD
Trametinib—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000435	0.0104	CcSEcCtD
Trametinib—Headache—Ramipril—type 1 diabetes mellitus	0.000433	0.0103	CcSEcCtD
Trametinib—Nausea—Ramipril—type 1 diabetes mellitus	0.00041	0.00978	CcSEcCtD
Trametinib—MAP2K1—Downstream signal transduction—IL6—type 1 diabetes mellitus	0.000187	0.000205	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000187	0.000205	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—INS—type 1 diabetes mellitus	0.000186	0.000205	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—IL6—type 1 diabetes mellitus	0.000186	0.000204	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—IL6—type 1 diabetes mellitus	0.000185	0.000204	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—IL6—type 1 diabetes mellitus	0.000185	0.000204	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—IL6—type 1 diabetes mellitus	0.000185	0.000204	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HLA-DPB1—type 1 diabetes mellitus	0.000185	0.000203	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—IL6—type 1 diabetes mellitus	0.000185	0.000203	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CRP—type 1 diabetes mellitus	0.000184	0.000203	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—IL6—type 1 diabetes mellitus	0.000184	0.000202	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—STAT3—type 1 diabetes mellitus	0.000184	0.000202	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—IL6—type 1 diabetes mellitus	0.000183	0.000202	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HLA-E—type 1 diabetes mellitus	0.000182	0.0002	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—IL6—type 1 diabetes mellitus	0.000182	0.0002	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—IL6—type 1 diabetes mellitus	0.000181	0.000199	CbGpPWpGaD
Trametinib—MAP2K1—Disease—B2M—type 1 diabetes mellitus	0.000181	0.000199	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000181	0.000199	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—STAT3—type 1 diabetes mellitus	0.000181	0.000199	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.00018	0.000198	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000179	0.000196	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000179	0.000196	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000178	0.000196	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CTLA4—type 1 diabetes mellitus	0.000175	0.000193	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000175	0.000192	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000175	0.000192	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—INS—type 1 diabetes mellitus	0.000174	0.000192	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CD80—type 1 diabetes mellitus	0.000174	0.000192	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000174	0.000191	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—IL6—type 1 diabetes mellitus	0.000173	0.00019	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—IL6—type 1 diabetes mellitus	0.000173	0.00019	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—IL6—type 1 diabetes mellitus	0.000173	0.00019	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HLA-DPB1—type 1 diabetes mellitus	0.000173	0.00019	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—STAT3—type 1 diabetes mellitus	0.000172	0.000189	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—IL6—type 1 diabetes mellitus	0.000172	0.000189	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HLA-E—type 1 diabetes mellitus	0.00017	0.000187	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—IL6—type 1 diabetes mellitus	0.00017	0.000187	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—IL6—type 1 diabetes mellitus	0.000169	0.000186	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000169	0.000186	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—STAT3—type 1 diabetes mellitus	0.000169	0.000186	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000168	0.000185	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000168	0.000185	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD79A—type 1 diabetes mellitus	0.000167	0.000184	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000167	0.000184	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000167	0.000184	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TYK2—type 1 diabetes mellitus	0.000166	0.000183	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PRKCQ—type 1 diabetes mellitus	0.000164	0.000181	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CTLA4—type 1 diabetes mellitus	0.000164	0.00018	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—EGFR—type 1 diabetes mellitus	0.000164	0.00018	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—IL6—type 1 diabetes mellitus	0.000164	0.00018	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000163	0.00018	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CD80—type 1 diabetes mellitus	0.000163	0.000179	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000163	0.000179	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NOS1—type 1 diabetes mellitus	0.000162	0.000178	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—VAV1—type 1 diabetes mellitus	0.000159	0.000175	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.000158	0.000174	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000157	0.000173	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD79A—type 1 diabetes mellitus	0.000157	0.000172	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—HBA2—type 1 diabetes mellitus	0.000156	0.000172	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TYK2—type 1 diabetes mellitus	0.000156	0.000171	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HLA-DQA1—type 1 diabetes mellitus	0.000154	0.00017	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PRKCQ—type 1 diabetes mellitus	0.000154	0.000169	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—EGFR—type 1 diabetes mellitus	0.000153	0.000169	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—IL6—type 1 diabetes mellitus	0.000153	0.000169	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PRKCQ—type 1 diabetes mellitus	0.000152	0.000167	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NOS1—type 1 diabetes mellitus	0.000151	0.000167	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000151	0.000166	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—VAV1—type 1 diabetes mellitus	0.000149	0.000164	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—EGFR—type 1 diabetes mellitus	0.000148	0.000163	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.000148	0.000163	CbGpPWpGaD
Trametinib—MAP2K2—Disease—VAV1—type 1 diabetes mellitus	0.000147	0.000162	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—TYK2—type 1 diabetes mellitus	0.000147	0.000162	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—G6PC2—type 1 diabetes mellitus	0.000147	0.000161	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HLA-DQA1—type 1 diabetes mellitus	0.000144	0.000159	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HLA-DQB1—type 1 diabetes mellitus	0.000144	0.000159	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PRKCQ—type 1 diabetes mellitus	0.000142	0.000156	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000142	0.000156	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000141	0.000155	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000141	0.000155	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000141	0.000155	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD86—type 1 diabetes mellitus	0.000139	0.000153	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—EGFR—type 1 diabetes mellitus	0.000139	0.000153	CbGpPWpGaD
Trametinib—MAP2K1—Disease—VAV1—type 1 diabetes mellitus	0.000138	0.000152	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—TYK2—type 1 diabetes mellitus	0.000138	0.000151	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD40LG—type 1 diabetes mellitus	0.000136	0.00015	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HLA-DQB1—type 1 diabetes mellitus	0.000135	0.000149	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000135	0.000148	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD8A—type 1 diabetes mellitus	0.000135	0.000148	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000133	0.000146	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CD4—type 1 diabetes mellitus	0.000133	0.000146	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000133	0.000146	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000132	0.000145	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000132	0.000145	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD86—type 1 diabetes mellitus	0.00013	0.000143	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HLA-B—type 1 diabetes mellitus	0.00013	0.000143	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CD86—type 1 diabetes mellitus	0.000128	0.000141	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL6—type 1 diabetes mellitus	0.000128	0.000141	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD40LG—type 1 diabetes mellitus	0.000128	0.00014	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ABCC8—type 1 diabetes mellitus	0.000127	0.00014	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000126	0.000139	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD8A—type 1 diabetes mellitus	0.000126	0.000139	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—IL6—type 1 diabetes mellitus	0.000126	0.000139	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—ERBB3—type 1 diabetes mellitus	0.000125	0.000138	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000124	0.000137	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CD4—type 1 diabetes mellitus	0.000124	0.000137	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SST—type 1 diabetes mellitus	0.000124	0.000136	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000123	0.000136	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL2RA—type 1 diabetes mellitus	0.000122	0.000134	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HLA-B—type 1 diabetes mellitus	0.000121	0.000133	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HLA-A—type 1 diabetes mellitus	0.00012	0.000132	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CD86—type 1 diabetes mellitus	0.00012	0.000132	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL6—type 1 diabetes mellitus	0.00012	0.000132	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—IL6—type 1 diabetes mellitus	0.000118	0.00013	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—ERBB3—type 1 diabetes mellitus	0.000117	0.000129	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—STAT3—type 1 diabetes mellitus	0.000117	0.000128	CbGpPWpGaD
Trametinib—MAP2K2—Disease—ERBB3—type 1 diabetes mellitus	0.000116	0.000127	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SST—type 1 diabetes mellitus	0.000116	0.000127	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000115	0.000127	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CRP—type 1 diabetes mellitus	0.000115	0.000126	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—IL6—type 1 diabetes mellitus	0.000114	0.000126	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CCR5—type 1 diabetes mellitus	0.000114	0.000125	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL2RA—type 1 diabetes mellitus	0.000114	0.000125	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HLA-A—type 1 diabetes mellitus	0.000112	0.000124	CbGpPWpGaD
Trametinib—MAP2K2—Disease—HLA-A—type 1 diabetes mellitus	0.000111	0.000122	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—GCG—type 1 diabetes mellitus	0.00011	0.000121	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HLA-DRB1—type 1 diabetes mellitus	0.00011	0.000121	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—STAT3—type 1 diabetes mellitus	0.000109	0.00012	CbGpPWpGaD
Trametinib—MAP2K1—Disease—ERBB3—type 1 diabetes mellitus	0.000108	0.000119	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CRP—type 1 diabetes mellitus	0.000107	0.000118	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—IL6—type 1 diabetes mellitus	0.000107	0.000117	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CCR5—type 1 diabetes mellitus	0.000107	0.000117	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000106	0.000117	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—EGFR—type 1 diabetes mellitus	0.000106	0.000117	CbGpPWpGaD
Trametinib—MAP2K1—Disease—HLA-A—type 1 diabetes mellitus	0.000104	0.000114	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000103	0.000113	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000103	0.000113	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000103	0.000113	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HLA-DRB1—type 1 diabetes mellitus	0.000103	0.000113	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD80—type 1 diabetes mellitus	0.000101	0.000112	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TNF—type 1 diabetes mellitus	0.000101	0.000111	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000101	0.000111	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	9.93e-05	0.000109	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—EGFR—type 1 diabetes mellitus	9.91e-05	0.000109	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NOS2—type 1 diabetes mellitus	9.65e-05	0.000106	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—VAV1—type 1 diabetes mellitus	9.65e-05	0.000106	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	9.62e-05	0.000106	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD80—type 1 diabetes mellitus	9.49e-05	0.000104	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TNF—type 1 diabetes mellitus	9.44e-05	0.000104	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	9.37e-05	0.000103	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CD80—type 1 diabetes mellitus	9.37e-05	0.000103	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—EGFR—type 1 diabetes mellitus	9.36e-05	0.000103	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IGF2—type 1 diabetes mellitus	9.34e-05	0.000103	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NOS2—type 1 diabetes mellitus	9.03e-05	9.93e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CD86—type 1 diabetes mellitus	8.99e-05	9.89e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—INS—type 1 diabetes mellitus	8.85e-05	9.73e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	8.77e-05	9.65e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CD80—type 1 diabetes mellitus	8.76e-05	9.64e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—EGFR—type 1 diabetes mellitus	8.75e-05	9.63e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IGF2—type 1 diabetes mellitus	8.74e-05	9.61e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—TYK2—type 1 diabetes mellitus	8.56e-05	9.42e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.53e-05	9.38e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ITPR3—type 1 diabetes mellitus	8.48e-05	9.33e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CD86—type 1 diabetes mellitus	8.41e-05	9.25e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	8.37e-05	9.21e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—INS—type 1 diabetes mellitus	8.28e-05	9.11e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—IL6—type 1 diabetes mellitus	8.14e-05	8.96e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	8.11e-05	8.92e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IFNG—type 1 diabetes mellitus	8.02e-05	8.82e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—TYK2—type 1 diabetes mellitus	8.01e-05	8.81e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—HBA1—type 1 diabetes mellitus	7.99e-05	8.78e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—E2F1—type 1 diabetes mellitus	7.98e-05	8.78e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.97e-05	8.77e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOC3—type 1 diabetes mellitus	7.94e-05	8.73e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—TYK2—type 1 diabetes mellitus	7.91e-05	8.7e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	7.87e-05	8.66e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.86e-05	8.64e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.8e-05	8.58e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GSTT1—type 1 diabetes mellitus	7.79e-05	8.57e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NOS3—type 1 diabetes mellitus	7.76e-05	8.54e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD4—type 1 diabetes mellitus	7.75e-05	8.52e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—IL6—type 1 diabetes mellitus	7.62e-05	8.38e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	7.59e-05	8.34e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IFNG—type 1 diabetes mellitus	7.5e-05	8.25e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.46e-05	8.21e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—TYK2—type 1 diabetes mellitus	7.4e-05	8.14e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.35e-05	8.09e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.3e-05	8.03e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NOS3—type 1 diabetes mellitus	7.26e-05	7.99e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD4—type 1 diabetes mellitus	7.25e-05	7.97e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—IL6—type 1 diabetes mellitus	7.19e-05	7.91e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	7.18e-05	7.9e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL1B—type 1 diabetes mellitus	7.15e-05	7.87e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CD4—type 1 diabetes mellitus	7.15e-05	7.87e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL2—type 1 diabetes mellitus	7.13e-05	7.84e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	6.83e-05	7.51e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—IL6—type 1 diabetes mellitus	6.73e-05	7.4e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL1B—type 1 diabetes mellitus	6.69e-05	7.36e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CD4—type 1 diabetes mellitus	6.69e-05	7.36e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL2—type 1 diabetes mellitus	6.67e-05	7.33e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CD80—type 1 diabetes mellitus	6.56e-05	7.21e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GCG—type 1 diabetes mellitus	6.21e-05	6.83e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—INS—type 1 diabetes mellitus	6.2e-05	6.82e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CD80—type 1 diabetes mellitus	6.14e-05	6.75e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—STAT3—type 1 diabetes mellitus	6e-05	6.6e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.99e-05	6.59e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.97e-05	6.56e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—INS—type 1 diabetes mellitus	5.8e-05	6.38e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—STAT3—type 1 diabetes mellitus	5.61e-05	6.17e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.61e-05	6.17e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.58e-05	6.14e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.54e-05	6.09e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—STAT3—type 1 diabetes mellitus	5.54e-05	6.09e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—EGFR—type 1 diabetes mellitus	5.45e-05	5.99e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.44e-05	5.98e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	5.4e-05	5.93e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CAT—type 1 diabetes mellitus	5.26e-05	5.78e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.18e-05	5.7e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—STAT3—type 1 diabetes mellitus	5.18e-05	5.7e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—EGFR—type 1 diabetes mellitus	5.1e-05	5.61e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.09e-05	5.59e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—EGFR—type 1 diabetes mellitus	5.03e-05	5.53e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—EGFR—type 1 diabetes mellitus	4.71e-05	5.18e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.61e-05	5.08e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL2—type 1 diabetes mellitus	4.61e-05	5.07e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.58e-05	5.04e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	4.55e-05	5.01e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.32e-05	4.75e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL2—type 1 diabetes mellitus	4.31e-05	4.74e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.29e-05	4.72e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	4.29e-05	4.71e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	4.26e-05	4.69e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL6—type 1 diabetes mellitus	4.19e-05	4.61e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	4.18e-05	4.6e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL6—type 1 diabetes mellitus	3.92e-05	4.31e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.88e-05	4.26e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IL6—type 1 diabetes mellitus	3.87e-05	4.25e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.63e-05	3.99e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IL6—type 1 diabetes mellitus	3.62e-05	3.98e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.52e-05	3.88e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—INS—type 1 diabetes mellitus	3.49e-05	3.84e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	3.33e-05	3.67e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.3e-05	3.63e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ALB—type 1 diabetes mellitus	3.2e-05	3.52e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—NOS3—type 1 diabetes mellitus	3.06e-05	3.37e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	2.82e-05	3.1e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL6—type 1 diabetes mellitus	2.71e-05	2.98e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.53e-05	2.79e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	1.87e-05	2.06e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	1.72e-05	1.89e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	1.64e-05	1.81e-05	CbGpPWpGaD
